Literature DB >> 9645710

Simian virus 40 T antigen-induced gonadotroph adenomas: a model of human null cell adenomas.

T R Kumar1, K E Graham, S L Asa, M J Low.   

Abstract

The cell of origin of human null cell pituitary adenomas is disputed. Although these tumors, by definition, do not produce any of the anterior pituitary hormones in vivo, they have been shown to express gonadotropin subunit genes, release gonadotropin hormones in vitro, and express the gonadotroph-associated transcription factor steroidogenic factor-1. However, they demonstrate variable responses to releasing hormones in vitro, raising questions about their origin from differentiated gonadotrophs or pluripotent stem cells. In this set of experiments, transgenic mice carrying a temperature-sensitive mutant (TSA58) of simian virus 40 T antigen driven by human FSHbeta regulatory elements were produced. These animals developed slow growing, multifocal pituitary nodules that demonstrated secretion of FSH with serum FSH levels 10-fold higher in male transgenic animals and 5-fold higher in female transgenic animals than those in nontransgenic controls. Anterior pituitary pathology progressed from diffuse gonadotroph hyperplasia to nodular adenomas with persistent, but decreasing, immunoreactivity for FSHbeta and LHbeta. Ultrastructural characteristics of the tumors were identical to those of human null cell adenomas. These results support the hypothesis that human null cell adenomas are derived from gonadotrophs and provide an animal model for further study of this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645710     DOI: 10.1210/endo.139.7.6100

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas.

Authors:  Mansur E Shomali; Laurence Katznelson
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

2.  A kinase activity associated with simian virus 40 large T antigen phosphorylates upstream binding factor (UBF) and promotes formation of a stable initiation complex between UBF and SL1.

Authors:  W Zhai; L Comai
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 3.  Gene therapy for pituitary tumors.

Authors:  Adriana Seilicovich; Daniel Pisera; Sandra A Sciascia; Marianela Candolfi; Mariana Puntel; Weidong Xiong; Gabriela Jaita; Maria G Castro
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

Review 4.  Molecular determinants of pituitary cytodifferentiation.

Authors:  S L Asa; S Ezzat
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

5.  Expression of a gonadotropin-releasing hormone receptor-simian virus 40 T-antigen transgene has sex-specific effects on the reproductive axis.

Authors:  Kyeong-Hoon Jeong; John C Gill; Vania Nosé; Albert F Parlow; Rona S Carroll; Ursula B Kaiser
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

6.  Endocrine surgical pathology: lesson from pituitary cases that are discordant between clinical and pathologic diagnoses.

Authors:  Toshiaki Sano; Shozo Yamada; Yasunori Ozawa; Akira Shimatsu
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

7.  Transgenic mouse technology: principles and methods.

Authors:  T Rajendra Kumar; Melissa Larson; Huizhen Wang; Jeff McDermott; Illya Bronshteyn
Journal:  Methods Mol Biol       Date:  2009

8.  "Honeycomb Golgi" in pituitary adenomas: not a marker of gonadotroph adenomas.

Authors:  Toshiaki Sano; Rene Mader; Sylvia L Asa; Zhi Rong Qian; Akiko Hino; Shozo Yamada
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

9.  Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas.

Authors:  Roger Gejman; Dalia L Batista; Ying Zhong; Yunli Zhou; Xun Zhang; Brooke Swearingen; Constantine A Stratakis; E Tessa Hedley-Whyte; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2008-07-15       Impact factor: 5.958

Review 10.  Genetically engineered mouse models of pituitary tumors.

Authors:  David A Cano; Alfonso Soto-Moreno; Alfonso Leal-Cerro
Journal:  Front Oncol       Date:  2014-08-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.